Vivian Sanders
Corporate Director of Marketing and Business Development
Replay available
Nutex Health Inc. (NASDAQ: NUTX) Q2 2025 earnings conference call, held 2025-08-25. Replay captured from the company's public earnings webcast.

Corporate Director of Marketing and Business Development
Chairman and CEO
Chief Financial Officer
President
Chief Medical Officer
Analyst, Maxim Group
Analyst, Freedom Capital
Analyst, North Bank Capital
Watch the replay and follow the connected company analysis, news, and investor updates for Nutex Health Inc..
WEBVTT 00:00:00.031 -- 00:00:04.776 Greetings and welcome to the NewTex Health Shareholders Update conference call. 00:00:04.776 -- 00:00:08.580 At this time, all participants are in a listen-only mode. 00:00:08.580 -- 00:00:12.765 A brief question and answer session will follow the formal presentation. 00:00:12.765 -- 00:00:16.769 If anyone should require operator assistance during the conference, please press star 00:00:16.769 -- 00:00:19.472 zero on your telephone keypad. 00:00:19.472 -- 00:00:21.775 As a reminder, this conference is being recorded. 00:00:21.775 -- 00:00:23.517 It 00:00:23.517 -- 00:00:28.122 is now my pleasure to introduce your host, Vivian Sanders, Corporate Director of Marketing 00:00:28.122 -- 00:00:32.454 and Business Development. Thank you. You may begin. 00:00:33.719 -- 00:00:39.067 Good morning, everyone, and welcome to Nutex Health Inc's second quarter 2025 company 00:00:39.067 -- 00:00:44.575 update conference call. I'm Vivian Sanders, and I'm pleased to moderate today's discussion. 00:00:44.575 -- 00:00:50.064 Thank you for joining us as we review our performance and outline our plans for the future. 00:00:50.064 -- 00:00:55.249 This call is being recorded, and a replay will be available on our website. 00:00:55.572 -- 00:01:01.018 With me today are our key leaders, Dr. Tom Vo, Chairman and CEO, 00:01:01.018 -- 00:01:06.745 John Bates, Chief Financial Officer, Dr. Warren Hossinian, President, 00:01:06.745 -- 00:01:09.789 and Dr. Mike Chang, Chief Medical Officer. 00:01:09.789 -- 00:01:13.333 They will provide insights into our financial results, 00:01:13.333 -- 00:01:18.819 operational progress, clinical quality, and strategic direction, followed by a Q&A 00:01:18.819 -- 00:01:20.819 session. 00:01:21.222 -- 00:01:26.802 Before we begin...